FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

PANACEABIO Share Price Discussion

Panacea Biotec Ltd.
NSE: PANACEABIO | BSE: 531349 | ISIN: INE922B01023 | Sector: Pharmaceuticals and health care

PANACEABIO Rating

0/5 (0 Ratings)
PANACEABIO Share Price *
110.85 -1.3 (-1.16%)
* (quote may be delayed)
Find answers to all your questions on live PANACEABIO message board: Is PANACEABIO buy or sell? Should I buy PANACEABIO shares? Why are PANACEABIO shares falling? Should I invest in PANACEABIO stock?

You can also check PANACEABIO share price target recommended by brokerages.

PANACEABIO Discussion Forum

@dineshgupta • Reputation: 2,123
PANACEABIO

Type
Buy
Instrument
PANACEABIO
Entry Price
₹138.8
Price@Trade
₹138.8
Target Price
₹165
Stop Price
₹125
Valid Till
Jan 14, 2021 3:20 AM
Margin
₹138.8 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹125
Net P&L
-9.94% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Jan 31 3:11 AM

Update
Stoploss Hit
Exit Price
₹125
@invictotrader • Reputation: 1,348

Panacea Biotec bags orders worth US$ 24 million from UN agencies
Like
reply
Reply
@invictotrader • Reputation: 1,348

Panacea Biotec receives USD 24.32 Million Award of Pentavalent Vaccine from U.N. Agencies
Like
reply
Reply

Panacea Biotec Gets $24.32 Mln Award Of Pentavalent Vaccine From U.N. Agencies - Reuters
Like
reply
Reply

Panacea Biotec has received orders worth $24.32 million from UN agencies.
Like
reply
Reply
@newsbot • Reputation: 2,308
Panacea Biotec Q1 loss narrows to Rs 28.27 cr
The company had posted a net loss of Rs 35.26 crore from continuing and discontinued operations for the corresponding period of the previous fiscal, Panacea Biotec said in a regulatory filing.
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@450264 • Reputation: 136

This month range tell me sir please
Like
reply
Reply
@neeraj • Reputation: 1,526

Free call - Panaceaabio blasting today. now trading at 209. already 5-6% up today
1
reply
Reply (3)
Latest replies
Neeraj Puri Goswami @neeraj
Apr 3 3:30 AM

Panaceabio free call suggested at 209. now touched 214.40. Hope you enjoying this free call
450264 @450264
Apr 3 6:03 AM

Dear sir I m buying 212.83 at 900 qty please ref me sir
Neeraj Puri Goswami @neeraj
Apr 3 6:03 AM

This call is already closed
@neeraj • Reputation: 1,526

Free call - PanaceaBio blasting today. CMP 198

#equity #intraday #nse #bse #nifty #nifty50
1
reply
Reply (8)
Latest replies
Neeraj Puri Goswami @neeraj
Mar 28 6:51 AM

Thanks sir jee
Neeraj Puri Goswami @neeraj
Mar 28 6:53 AM

i suggested at 198. from there it touched 202.65. thats also good gains dear
Arun Prasath V @arunprasathv
Mar 28 6:55 AM

However, 4 rupees for free call within mins is also good one ji...
Neeraj Puri Goswami @neeraj
Mar 28 8:28 AM

Panaceabio free call was suggested at 198. now touched high 205. Hope you enjoyed this free call
Neeraj Puri Goswami @neeraj
Mar 28 8:47 AM

Panaceabio free call given at 198. now made high 207.05
@newsbot • Reputation: 2,308
Like
reply
Reply

How to pay
Like
reply
Reply
@neeraj • Reputation: 1,526

Free call - Start watching - Panaceabio now at 179 #equity #intraday
Like
reply
Reply
@neeraj • Reputation: 1,526

Start watching - Panaceabio now at 164
Like
reply
Reply (1)
Latest replies
Neeraj Puri Goswami @neeraj
Dec 24 5:20 AM

Panaceabio free call given at 164. now made high 168
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.